These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10985887)

  • 1. NK cell activity in the presence of IL-12 is a prognostic assay to neoadjuvant chemotherapy in cervical cancer.
    Cosiski Marana HR; Santana da Silva J; Moreira de Andrade J
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):318-23. PubMed ID: 10985887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cells and interleukin-12 in patients with advanced cervical cancer under neoadjuvant chemotherapy.
    Marana HR; Andrade JM; Silva JS
    Braz J Med Biol Res; 1996 Apr; 29(4):473-7. PubMed ID: 8736110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of neoadjuvant polychemotherapy on natural killer cell activity in patients with locally advanced cervical squamous carcinoma.
    Garzetti GG; Ciavattini A; Provinciali M; Valensise H; Romanini C; Fabris N
    Gynecol Oncol; 1994 Jan; 52(1):39-43. PubMed ID: 7508412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma].
    Cheng XD; Lü WG; Ye F; Chen HZ; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12 and IL-2 potentiate the in vitro tumor-specific activity of peripheral blood cells from cervical cancer patients.
    Verma V; Sharma V; Shrivastava SK; Nadkarni JJ
    J Exp Clin Cancer Res; 2000 Sep; 19(3):367-74. PubMed ID: 11144531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation.
    Porrata LF; Inwards DJ; Lacy MQ; Markovic SN
    Bone Marrow Transplant; 2001 Oct; 28(7):673-80. PubMed ID: 11704790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
    Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE
    Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant therapy changes the lymphocyte composition of tumor-draining lymph nodes in cervical carcinoma.
    Fattorossi A; Battaglia A; Ferrandina G; Coronetta F; Legge F; Salutari V; Scambia G
    Cancer; 2004 Apr; 100(7):1418-28. PubMed ID: 15042676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report.
    Fuso L; Mazzola S; Marocco F; Ferrero A; Dompè D; Carus AP; Zola P
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S187-91. PubMed ID: 16185756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
    Kobashi K; Iwagaki H; Yoshino T; Morimoto Y; Kohka H; Kodama M; Nishibori M; Akagi T; Tanaka N
    Anticancer Res; 2001; 21(5):3285-93. PubMed ID: 11848485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy.
    Pongnikorn S; Fongmoon D; Kasinrerk W; Limtrakul PN
    J Med Assoc Thai; 2003 Jan; 86(1):61-8. PubMed ID: 12678140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective changes in the immune profile of tumor-draining lymph nodes after different neoadjuvant chemoradiation regimens for locally advanced cervical cancer.
    Battaglia A; Buzzonetti A; Martinelli E; Fanelli M; Petrillo M; Ferrandina G; Scambia G; Fattorossi A
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1546-53. PubMed ID: 20338481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix.
    Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K
    Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+CD45RA+CD27-CD28-T-cell subset in PBL of cervical cancer patients representing CD8+T-cells being able to recognize cervical cancer associated antigens provided by HPV 16 E7.
    Pilch H; Hoehn H; Schmidt M; Steiner E; Tanner B; Seufert R; Maeurer M
    Zentralbl Gynakol; 2002; 124(8-9):406-12. PubMed ID: 12655469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy.
    Shaw SG; Maung AA; Steptoe RJ; Thomson AW; Vujanovic NL
    J Immunol; 1998 Sep; 161(6):2817-24. PubMed ID: 9743341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy.
    Choi CH; Song SY; Choi JJ; Park YA; Kang H; Kim TJ; Lee JW; Kim BG; Lee JH; Bae DS
    BMC Cancer; 2008 Oct; 8():295. PubMed ID: 18847499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma.
    Costa S; Terzano P; Bovicelli A; Martoni A; Angelelli B; Santini D; Ceccarelli C; Lipponen P; Erzén M; Syrjänen S; Syrjänen K
    Gynecol Oncol; 2001 Jan; 80(1):67-73. PubMed ID: 11136572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of IL-2 and IL-4 in patients with tobacco-related oral squamous cell carcinoma.
    Manchanda P; Sharma SC; Das SN
    Oral Dis; 2006 Sep; 12(5):455-62. PubMed ID: 16910915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of peripheral T-lymphocyte subsets and natural killer cells in patients with colorectal cancer.
    Qiu H; Xiao-Jun W; Zhi-Wei Z; Gong C; Guo-Qiang W; Li-Yi Z; Yuan-Fang L; Rajiv-Prasad K
    Hepatogastroenterology; 2009; 56(94-95):1310-5. PubMed ID: 19950782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.